| P2093 | author name string | Clemente J Britto | |
| | Lauren Cohn | |
| P2860 | cites work | Linking acute infection to chronic lung disease. The role of IL-33-expressing epithelial progenitor cells | Q26827549 |
| | Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation | Q28072864 |
| | SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production | Q28507392 |
| | Airway mucus function and dysfunction | Q33723578 |
| | A GABAergic system in airway epithelium is essential for mucus overproduction in asthma | Q34641380 |
| | Distinct roles of FOXA2 and FOXA3 in allergic airway disease and asthma. | Q34658887 |
| | Airway epithelial transcription factor NK2 homeobox 1 inhibits mucous cell metaplasia and Th2 inflammation | Q35219741 |
| | Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease | Q37516982 |
| | Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases | Q38671055 |
| | Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung Cancer | Q39070730 |
| | New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait! | Q39352939 |
| | Viral induction of a chronic asthma phenotype and genetic segregation from the acute response | Q39738116 |
| | Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease | Q42464328 |
| | Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression | Q46727427 |
| | Why do BCL-2 inhibitors work and where should we use them in the clinic? | Q47159040 |
| | Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches. | Q47649999 |
| | Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. | Q50199742 |
| | A Small Molecule BH3-mimetic Suppresses Cigarette Smoke-Induced Mucous Expression in Airway Epithelial Cells | Q58740933 |
| | Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack | Q68084501 |
| | SMAD Signaling Restricts Mucous Cell Differentiation in Human Airway Epithelium | Q92221320 |
| | Airway Epithelial Differentiation and Mucociliary Clearance | Q93091785 |
| P433 | issue | 3 | |
| P304 | page(s) | 275-276 | |
| P577 | publication date | 2019-09-01 | |
| P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
| P1476 | title | Escalating Mucus Inhibition to the Top of Our Priorities | |
| P478 | volume | 61 | |